Dermfree Numbing

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of pain and itching associated with minor burns, sunburn, insect bites, scrapes, and minor skin irritations.

Limitations of Use: This product is intended for external use only and should not be applied to large areas of the body or on deep puncture wounds, animal bites, or serious burns.

Dosage and Administration

Healthcare professionals should begin by cleansing the targeted skin area thoroughly and patting it dry before application. A thin layer of the medication should then be applied to the affected area. This application may be performed up to 3 to 4 times daily, ensuring that the total daily applications do not exceed this frequency. Care should be taken to avoid applying more than the recommended amount to prevent potential adverse effects.

Contraindications

Use is contraindicated in the following situations:

Application on large areas of the body is not recommended due to the potential for systemic absorption and associated adverse effects.

The product should not be applied to broken, blistered, or abraded skin, as this may increase the risk of systemic exposure and local irritation.

Patients with a known allergy to local anesthetics, including lidocaine, benzocaine, or other "caine" derivatives, should not use this product due to the risk of severe allergic reactions.

Warnings and Precautions

For external use only. It is imperative that healthcare professionals advise patients to adhere strictly to this guideline to prevent any adverse effects associated with inappropriate use.

In the event of accidental ingestion, immediate medical assistance should be sought. Patients or caregivers are advised to contact a Poison Control Center or seek emergency medical help without delay.

Healthcare providers should instruct patients to discontinue use and consult a physician under the following circumstances: if the condition worsens or fails to improve within 7 days; if an allergic reaction to any of the product's ingredients occurs; or if symptoms persist, including the presence of redness or irritation at the application site. These precautions are essential to ensure patient safety and effective management of their condition.

Side Effects

For external use only. Patients should discontinue use and consult a healthcare professional if the condition worsens or does not improve within 7 days. Additionally, an allergic reaction to any ingredients in this product warrants immediate cessation of use and medical advice. If the symptoms being treated do not subside, or if redness or irritation occurs, patients are advised to seek medical attention.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Dermfree Numbing (menthol 5% numbing). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of DERMFREE NUMBING (menthol 5% numbing cream) in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution when considering the use of this product in patients aged 65 and older, as the absence of data necessitates careful monitoring and individualized assessment of treatment risks and benefits in this population.

Pregnancy

There is no information available regarding the use of DERMFREE NUMBING menthol 5% numbing cream during pregnancy. Consequently, safety concerns, dosage modifications, or special precautions for pregnant patients have not been established. Healthcare professionals should exercise caution when considering the use of this product in women of childbearing potential, as the lack of data precludes a comprehensive assessment of potential risks to fetal outcomes. It is advisable to weigh the benefits against any unknown risks when prescribing this medication to pregnant patients.

Lactation

There is no specific information available regarding the use of DERMFREE NUMBING (menthol 5% numbing cream) in lactating mothers or its effects on breastfed infants. Healthcare professionals should exercise caution and consider the potential risks and benefits when recommending this product to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on clinical judgment.

For further guidance, healthcare professionals may refer to established protocols for managing drug overdosage or consult a poison control center.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients not to apply the product to large areas of the body or on broken, blistered, or abraded skin.

Patients should be informed that they should not use the product if they have a known allergy to local anesthetics, including lidocaine, benzocaine, or other "caine" derivatives. They should be counseled to discontinue use if their condition worsens or does not improve within 7 days. Additionally, patients should stop using the product if they experience any allergic reactions to its ingredients or if the symptoms being treated do not subside, or if redness or irritation occurs.

While using the product, patients must be cautioned to avoid contact with the eyes. They should also be advised against tightly bandaging the area of application or using the product in conjunction with a heating pad. It is essential to emphasize that the product should only be used as directed.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 15-30°C (59-86°F) to maintain its efficacy. Care should be taken to protect the product from excessive heat and direct sunlight to ensure optimal storage conditions. The product should be used only as directed to ensure safety and effectiveness.

Additional Clinical Information

The medication is administered topically, with a recommended application of a thin layer to the affected area, not exceeding 3-4 times daily. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Dermfree Numbing, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)